First Time Loading...
S

Shanghai Kai Kai Industry Co Ltd
SSE:600272

Watchlist Manager
Shanghai Kai Kai Industry Co Ltd
SSE:600272
Watchlist
Price: 10.05 CNY -2.43% Market Closed
Updated: May 21, 2024

Shanghai Kai Kai Industry Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Kai Kai Industry Co Ltd
Cost of Revenue Peer Comparison

Comparables:
C
1093
H
3692
600436
600276
000538

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Kai Kai Industry Co Ltd
SSE:600272
Cost of Revenue
-¥781m
CAGR 3-Years
-12%
CAGR 5-Years
-3%
CAGR 10-Years
-1%
C
CSPC Pharmaceutical Group Ltd
HKEX:1093
Cost of Revenue
-¥9.3B
CAGR 3-Years
-14%
CAGR 5-Years
-9%
CAGR 10-Years
-6%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Cost of Revenue
-¥1B
CAGR 3-Years
-9%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Cost of Revenue
-¥5.7B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Cost of Revenue
-¥3.8B
CAGR 3-Years
0%
CAGR 5-Years
-7%
CAGR 10-Years
-11%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Cost of Revenue
-¥28.9B
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
-9%

See Also

What is Shanghai Kai Kai Industry Co Ltd's Cost of Revenue?
Cost of Revenue
-781m CNY

Based on the financial report for Mar 31, 2024, Shanghai Kai Kai Industry Co Ltd's Cost of Revenue amounts to -781m CNY.

What is Shanghai Kai Kai Industry Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-1%

Over the last year, the Cost of Revenue growth was -11%. The average annual Cost of Revenue growth rates for Shanghai Kai Kai Industry Co Ltd have been -12% over the past three years , -3% over the past five years , and -1% over the past ten years .